To verify our finding, we applied Kaplan-Meier analysis to the GSE48075 cohort and found that the prognostic value of TOX3 lacked statistical significance (p = 0.17), but that BLCA patients in the SORL1 high-expression group showed significantly (p = 0.0065) more favourable OS outcomes than those in the SORL1 low-expression group in the GEO validation cohort (Figures 4C,D). The gene discussed is SORL1; the disease is bladder transitional cell carcinoma.